Cargando…
Can Extracellular Vesicles as Drug Delivery Systems Be a Game Changer in Cardiac Disease?
Cardiac diseases such as myocardial infarction and heart failure have been the leading cause of death worldwide for more than 20 years, and new treatments continue to be investigated. Heart transplantation, a curative treatment for severe cardiac dysfunction, is available to only a small number of p...
Autores principales: | Okamura, Akihiko, Yoshioka, Yusuke, Saito, Yoshihiko, Ochiya, Takahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126064/ https://www.ncbi.nlm.nih.gov/pubmed/36577860 http://dx.doi.org/10.1007/s11095-022-03463-z |
Ejemplares similares
-
Challenges for the Development of Extracellular Vesicle-Based Nucleic Acid Medicines
por: Kuriyama, Naoya, et al.
Publicado: (2021) -
Extracellular vesicle transfer of cancer pathogenic components
por: Fujita, Yu, et al.
Publicado: (2016) -
Biocompatibility of highly purified bovine milk-derived extracellular vesicles
por: Somiya, Masaharu, et al.
Publicado: (2018) -
Extracellular Vesicles in Cancer Metastasis: Potential as Therapeutic Targets and Materials
por: Kogure, Akiko, et al.
Publicado: (2020) -
Can Artemisinin Be a Game Changer Even as an Antiarrhythmic Drug?
por: Hwang, Jongmin
Publicado: (2023)